Product NDC: | 0143-9673 |
Proprietary Name: | Levetiracetam |
Non Proprietary Name: | Levetiracetam |
Active Ingredient(s): | 100 mg/mL & nbsp; Levetiracetam |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0143-9673 |
Labeler Name: | West-ward Pharmaceutical Corp |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090981 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120220 |
Package NDC: | 0143-9673-10 |
Package Description: | 10 VIAL, GLASS in 1 BOX (0143-9673-10) > 5 mL in 1 VIAL, GLASS |
NDC Code | 0143-9673-10 |
Proprietary Name | Levetiracetam |
Package Description | 10 VIAL, GLASS in 1 BOX (0143-9673-10) > 5 mL in 1 VIAL, GLASS |
Product NDC | 0143-9673 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Levetiracetam |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20120220 |
Marketing Category Name | ANDA |
Labeler Name | West-ward Pharmaceutical Corp |
Substance Name | LEVETIRACETAM |
Strength Number | 100 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |